| 000 | 01075 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516021734.0 | ||
| 264 | 0 | _c20110613 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1471-499X | ||
| 024 | 7 |
_a10.1016/j.molmed.2010.12.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorandi, Andrea | |
| 245 | 0 | 0 |
_aRET in breast cancer: functional and therapeutic implications. _h[electronic resource] |
| 260 |
_bTrends in molecular medicine _cMar 2011 |
||
| 300 |
_a149-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-ret _xantagonists & inhibitors |
| 700 | 1 | _aPlaza-Menacho, Ivan | |
| 700 | 1 | _aIsacke, Clare M | |
| 773 | 0 |
_tTrends in molecular medicine _gvol. 17 _gno. 3 _gp. 149-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molmed.2010.12.007 _zAvailable from publisher's website |
| 999 |
_c20533227 _d20533227 |
||